表紙
市場調査レポート

薬剤給付管理 (PBM) の米国市場:2015年〜2019年

Pharmacy Benefit Manager (PBM) Market in the US 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 346689
出版日 ページ情報 英文 69 Pages
即納可能
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。
Back to Top
薬剤給付管理 (PBM) の米国市場:2015年〜2019年 Pharmacy Benefit Manager (PBM) Market in the US 2015-2019
出版日: 2015年12月09日 ページ情報: 英文 69 Pages
概要

米国の薬剤給付管理 (PBM) 市場は、2014年から2019年の間、7.16%のCAGRで拡大する見込みです。

当レポートでは、米国における薬剤給付管理 (PBM) 市場の現状の分析と今後の成長見通し、市場の成長因子と課題、主な動向、主要ベンダーの分析などとともにお届けします。

第1章 エグゼクティブサマリー

  • 概況

第2章 当レポートの調査範囲

  • 市場概要
  • 主要ベンダーの製品

第3章 市場調査手法

  • 調査手法
  • 経済指標

第4章 イントロダクション

  • 主な市場洞察

第5章 米国の経済プロファイル

第6章 世界の医薬品市場

  • 世界の医薬品市場
  • 米国の医薬品市場

第7章 PBMの概要

第8章 米国のPBM市場

  • 市場概要
  • 市場規模と予測
  • Medicare加入者
  • Medicaid加入者
  • ファイブフォース分析

第9章 市場成長因子

第10章 市場成長因子の影響

第11章 市場の課題

第12章 成長因子と課題の影響

第13章 市場動向

第14章 ベンダー情勢

  • 競合シナリオ
  • 市場シェア分析
  • その他の有力ベンダー

第15章 主要ベンダーの分析

  • Catamaran
  • CVS Health
  • Express Scripts
  • OptumRx
  • Prime Therapeutics

第16章 その他の有力ベンダー

  • Aetna
  • Argus Health Systems
  • Centene
  • Cigna
  • Humana
  • MedImpact
  • Rite Aid

第17章 付録

  • 略語リスト

第18章 Technavioについて

目次
Product Code: IRTNTR7502

About PBMs

PBMs are responsible for processing prescriptions for corporations or insurance companies. Earlier, their major role was administration and negotiation with drug pharmacies and manufacturers to get rebates on drug prices. Now they have evolved into entities taking over the drug benefit portion of health plans in the US. Recent healthcare reforms in the US have contributed significantly to increase their area of expertise. Increase in costs of drugs and other healthcare services has made PBM's services more desirable. PBMs act as an intermediary between the payer and other entities in a healthcare system. They generate revenue through service fees they charge from large customer contracts for activities such as operating mail-order pharmacies, processing prescriptions, and negotiating with drug manufacturers and pharmacies.

Technavio's analysts forecast the PBM market in the US to grow at a CAGR of 7.16% during 2014-2019.

Covered in this report

The report covers the current scenario and the growth prospects of the PBM market in the US for the period of 2015-2019. To calculate the market size, the report considers revenue generated by PBMs by offering pharmacy benefit services to end-users in the healthcare market in the US.

Technavio's report, Pharmacy Benefit Manager (PBM) Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the PBM market landscape in the US and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Catamaran
  • CVS Health (CVS Caremark)
  • Express Scripts
  • OptumRx
  • Prime Therapeutics

Other Prominent Vendors

  • Aetna
  • Argus Health Systems
  • Centene
  • Cigna
  • Humana
  • Medlmpact
  • Rite Aid

Market driver

  • Increase in healthcare expenditure
  • For a full, detailed list, view our report

Market challenge

  • Criticisms of PBMs
  • For a full, detailed list, view our report

Market trend

  • Shift toward multi-tier prescription drug plans by employers
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: US: Economic profile

PART 06: Global pharmaceuticals market

  • Global pharmaceuticals market
  • US pharmaceuticals market

PART 07: PBM: An overview

PART 08: PBM market in US

  • Market overview
  • Market size and forecast
  • PBM market in US by Medicare members
  • PBM market in US by managed Medicaid members
  • Five forces analysis

PART 09: Market drivers

PART 10: Impact of drivers

PART 11: Market challenges

PART 12: Impact of drivers and challenges

PART 13: Market trends

PART 14: Vendor landscape

  • Competitive scenario
  • Market share analysis 2014
  • Other prominent vendors

PART 15: Key vendor analysis

  • Catamaran
  • CVS Health
  • Express Scripts
  • OptumRx
  • Prime Therapeutics

PART 16: Other prominent vendors

  • Aetna
  • Argus Health Systems
  • Centene
  • Cigna
  • Humana
  • MedImpact
  • Rite Aid

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: US GDP 2009-2014 ($ trillions)
  • Exhibit 03: US GDP per capita 2009-2014 ($ thousands)
  • Exhibit 04: US population 2009-2014 (millions)
  • Exhibit 05: US population by age group 2014
  • Exhibit 06: Global pharmaceuticals market 2014-2019 ($ trillions)
  • Exhibit 07: Global pharmaceuticals market by geography 2014
  • Exhibit 08: Pharmaceuticals market in US 2006-2013 ($ billions)
  • Exhibit 09: Pharmaceuticals market in US 2014-2019 ($ billions)
  • Exhibit 10: US drug approvals: Specialty versus traditional drugs 2006-2014
  • Exhibit 11: US prescription drug spending 2014-2019 ($ billions)
  • Exhibit 12: Per capita pharmaceutical spending: US versus other countries 2014 and 2019 ($)
  • Exhibit 13: PBMs: Areas of expertise
  • Exhibit 14: Key activities of PBMs
  • Exhibit 15: PBM market in US 2014-2019 ($ billions)
  • Exhibit 16: Growth of insurance in US 2014-2019 (millions of lives)
  • Exhibit 17: Growth in PBM-managed lives in US 2012-2019 (millions of lives)
  • Exhibit 18: PBM-managed lives under Medicare 2014-2019 (millions of lives)
  • Exhibit 19: Medicare members in US by PBM 2014
  • Exhibit 20: PBM-managed lives under managed Medicaid program 2014-2019 (millions of lives)
  • Exhibit 21: Managed Medicaid members in US by PBM 2014
  • Exhibit 22: Five forces analysis
  • Exhibit 23: Aging population in US 2010-2050
  • Exhibit 24: Decrease in mortality rate in US 2011-2012 (deaths per 100,000 in standard population)
  • Exhibit 25: Impact of drivers
  • Exhibit 26: Rise of private exchange contribution plans in US: 2010 versus 2014 (millions of lives)
  • Exhibit 27: US states with PBM regulations 2013
  • Exhibit 28: Impact of drivers and challenges
  • Exhibit 29: Specialty drugs market in US 2014-2019 ($ billions)
  • Exhibit 30: M&A in PBM market in US
  • Exhibit 31: PBM market in US: Vendor segmentation by revenue 2014
  • Exhibit 32: PBM market in US: Vendor segmentation by equivalent prescription 2014
  • Exhibit 33: PBM market in US: Vendor segmentation by PBM lives 2014
  • Exhibit 34: Business segmentation of Catamaran
  • Exhibit 35: Catamaran: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 36: Catamaran: Geographical segmentation by revenue 2014
  • Exhibit 37: CVS Health: Business segmentation by revenue 2014
  • Exhibit 38: Express Scripts: Business segmentation by revenue 2014
  • Exhibit 39: Express Scripts: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 40: OptumRx: Service segmentation
  • Exhibit 41: Prime Therapeutics: Business segmentation
Back to Top